Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Guangdong Dtech (鼎泰高科) A+H IPO: Analysis of Deal Terms

Guangdong Dtech Technology (鼎泰高科) IPO Trading

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Equity Capital Markets

Guangdong Dtech Technology / Equity Capital Markets

<ul>
<li>Guangdong Dtech Technology passed hearing for an A+H listing. CITIC and HSBC are the sponsors.</li>
<li>We look at the company's core segments: precision cutting tools and grinding and polishing materials.</li>
<li>We discussed our preliminary thoughts on the company's fair value based on A-H premium.</li>
</ul>


Guangdong Dtech Technology passed hearing for an A+H listing. CITIC and HSBC are the sponsors.
We look at the company's core segments: precision cutting tools and grinding and polishing materials.
We discussed our preliminary thoughts on the company's fair value based on A-H premium.


China Tungsten And Hightech Ma (000657 CH)

Shenzhen Han's CNC Technology (301200 CH)

Victory Giant Technology (HuiZhou) (2476 HK)

Guangdong Dtech Technology (鼎泰高科) A+H Pre-IPO: Early Thoughts